Safety and Efficacy of Clobetasol Propionate 0.05% Emollient Foam for the Treatment of Central Centrifugal Cicatricial Alopecia.

Conclusion: Subjects with CCCA that applied topical clobetasol propionate 0.05% emollient foam to their scalp daily demonstrated continuous clinical improvement throughout the 14-week study. ClinicalTrials.gov Identifier: NCT01111981 J Drugs Dermatol. 2020;19(7): doi:10.36849/JDD.2020.5201. PMID: 32726554 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32726554?dopt=Abstract

Source: Journal of Drugs in Dermatology - July 31, 2020 Category: Dermatology Tags: J Drugs Dermatol Source Type: research